Position in BCAB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$500
+$480 QoQ
Shares Held
121
-6.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 21 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in BCAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,919,879,903 across 425 Biotechnology names. BCAB ranks #374 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in BCAB
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $500 | 121 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $20 | 129 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $73 | 129 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $776 | 1,129 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $447 | 1,129 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $442 | 1,277 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $667 | 1,129 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,987 | 1,129 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $11,424 | 8,340 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $105,136 | 30,563 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $95,890 | 38,980 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $77,415 | 45,539 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $136,098 | 45,366 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $26,998 | 10,074 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $1,367,791 | 165,793 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $2,142,222 | 278,211 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $783,266 | 274,831 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $81,170 | 16,234 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $294,193 | 14,987 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $780,040 | 26,496 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $355,226 | 8,382 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $4,072,588 | 80,106 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $37,002 | 1,088 | Shares | Other | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||